Hepatocellular carcinoma recurrence after acute liver allograft rejection treatment. A multicenter European experience
01 Pubblicazione su rivista
Lai Q., Iesari S., Finkenstedt A., Hoppe-Lotichius M., Foguenne M., Lehner K., Otto G., Lerut J.
ISSN: 1499-3872
During the last decades, several risk factors for the recurrence of hepatocellular carcinoma (HCC) after liver transplantation (LT) have been investigated. However, the impact of two important drivers of oncogenesis, namely the immunosuppression and the treatment of acute cellular rejection (ACR) have been marginally addressed. This study aimed at investigating the impact of ACR treatment on the incidence of tumor recurrence in a large European HCC-LT population.